These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 25275300)

  • 21. HOX transcript antisense RNA (HOTAIR) in cancer.
    Qu X; Alsager S; Zhuo Y; Shan B
    Cancer Lett; 2019 Jul; 454():90-97. PubMed ID: 30981759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
    Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT
    Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA and Polycomb: an intricate partnership in cancer biology.
    Achour C; Aguilo F
    Front Biosci (Landmark Ed); 2018 Jun; 23(11):2106-2132. PubMed ID: 29772549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCYRN1: An oncogenic lncRNA in diverse cancers.
    Ghafouri-Fard S; Dashti S; Hussen BM; Farsi M; Taheri M
    Pathol Res Pract; 2021 Apr; 220():153385. PubMed ID: 33647864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.
    Zhang X; Xie K; Zhou H; Wu Y; Li C; Liu Y; Liu Z; Xu Q; Liu S; Xiao D; Tao Y
    Mol Cancer; 2020 Mar; 19(1):47. PubMed ID: 32122355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways.
    Alsaab HO; Alzahrani MS; F Alaqile A; Waggas DS; Almutairy B
    Pathol Res Pract; 2024 Aug; 260():155455. PubMed ID: 39043005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role and mechanism of HLA complex group 11 in cancer.
    Yuan X; Zhao Q; Zhang Y; Xue M
    Biomed Pharmacother; 2021 Nov; 143():112210. PubMed ID: 34563948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hallmarks of cancer: a long non-coding RNA point of view.
    Gutschner T; Diederichs S
    RNA Biol; 2012 Jun; 9(6):703-19. PubMed ID: 22664915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk between the lncRNA UCA1 and microRNAs in cancer.
    Xuan W; Yu H; Zhang X; Song D
    FEBS Lett; 2019 Aug; 593(15):1901-1914. PubMed ID: 31166011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
    Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer.
    Dinescu S; Ignat S; Lazar AD; Constantin C; Neagu M; Costache M
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30654440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer.
    Bhan A; Mandal SS
    Biochim Biophys Acta; 2015 Aug; 1856(1):151-64. PubMed ID: 26208723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
    Wu Y; Zhang L; Zhang L; Wang Y; Li H; Ren X; Wei F; Yu W; Liu T; Wang X; Zhou X; Yu J; Hao X
    Int J Oncol; 2015; 46(6):2586-94. PubMed ID: 25901533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.